Abstract
Introduction
Diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar syndrome (HHS) are life-threatening complications of diabetes mellitus. Their clinical profiles have not been fully investigated.
Methods
A multicenter retrospective cohort study was conducted in 21 acute care hospitals in Japan. Patients included were adults aged 18 or older who had been hospitalized from January 1, 2012, to December 31, 2016 due to DKA or HHS. The data were extracted from patient medical records. A four-group comparison (mild DKA, moderate DKA, severe DKA, and HHS) was performed to evaluate outcomes.
Results
A total of 771 patients including 545 patients with DKA and 226 patients with HHS were identified during the study period. The major precipitating factors of disease episodes were poor medication compliance, infectious diseases, and excessive drinking of sugar-sweetened beverages. The median hospital stay was 16 days [IQR 10–26 days]. The intensive care unit (ICU) admission rate was 44.4% (mean) and the rate at each hospital ranged from 0 to 100%. The in-hospital mortality rate was 2.8% in patients with DKA and 7.1% in the HHS group. No significant difference in mortality was seen among the three DKA groups.
Conclusions
The mortality rate of patients with DKA in Japan is similar to other studies, while that of HHS was lower. The ICU admission rate varied among institutions. There was no significant association between the severity of DKA and mortality in the study population.
Trial Registration
This study is registered in the UMIN clinical Trial Registration System (UMIN000025393, Registered 23th December 2016).
Similar content being viewed by others
Data availability
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
References
Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA (2006) Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American diabetes association. Diabetes Care 29:2739–2748. https://doi.org/10.2337/dc06-9916
French EK, Donihi AC, Korytkowski MT (2019) Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients. BMJ. https://doi.org/10.1136/bmj.l1114
Pasquel FJ, Umpierrez GE (2014) Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care 37:3124–3131. https://doi.org/10.2337/dc14-0984
Dhatariya KK, Nunney I, Higgins K et al (2016) National survey of the management of diabetic ketoacidosis (DKA) in the UK in 2014. Diabet Med 33:252–260. https://doi.org/10.1111/dme.12875
Fathallah N, Slim R, Larif S et al (2015) Drug-induced hyperglycaemia and diabetes. Drug Saf 38:1153–1168. https://doi.org/10.1007/s40264-015-0339-z
Gibb FW, Teoh WL, Graham J, Lockman KA (2016) Risk of death following admission to a UK hospital with diabetic ketoacidosis. Diabetologia 59:2082–2087. https://doi.org/10.1007/s00125-016-4034-0
Benoit SR, Zhang Y, Geiss LS, Gregg EW, Albright A (2018) Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality—United States, 2000–2014. Morb Mortal Wkly Rep 67(12):362. https://doi.org/10.15585/mmwr.mm6712a3
Barski L, Nevzorov R, Rabaev E et al (2012) Diabetic ketoacidosis: clinical characteristics, precipitating factors and outcomes of care. Isr Med Assoc J 14:298–302
Mekonnen GA, Gelaye KA, Gebreyohannes EA, Abegaz TM (2022) Treatment outcomes of diabetic ketoacidosis among diabetes patients in Ethiopia. Hosp Based Study PLoS One 17:1–15. https://doi.org/10.1371/journal.pone.0264626
Siregar NN, Soewondo P, Subekti I, Muhadi M (2018) Seventy-two hour mortality prediction model in patients with diabetic ketoacidosis: a retrospective cohort study. J ASEAN Fed Endocr Soc 33:124–129. https://doi.org/10.15605/jafes.033.02.03
Fadini GP, de Kreutzenberg SV, Rigato M et al (2011) Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. Diabetes Res Clin Pract 94:172–179. https://doi.org/10.1016/j.diabres.2011.06.018
Venkatesh B, Pilcher D, Prins J et al (2015) Incidence and outcome of adults with diabetic ketoacidosis admitted to ICUs in Australia and New Zealand. Crit Care 19:1–12. https://doi.org/10.1186/s13054-015-1171-7
Gershengorn HB, Iwashyna TJ, Cooke CR et al (2012) Variation in use of intensive care for adults with diabetic ketoacidosis. Crit Care Med 40:2009–2015. https://doi.org/10.1097/CCM.0b013e31824e9eae
Mendez Y, Surani S, Varon J (2017) Diabetic ketoacidosis: Treatment in the intensive care unit or general medical/surgical ward? World J Diabetes 8:40. https://doi.org/10.4239/wjd.v8.i2.40
Zhou VL, Shofer FS, Desai NG et al (2019) Predictors of short intensive care unit stay for patients with diabetic ketoacidosis using a novel emergency department-based resuscitation and critical care unit. J Emerg Med 56:127–134. https://doi.org/10.1016/j.jemermed.2018.09.048
George JT, Ajay Kumar Mishra RI (2018) Correlation between the outcomes and severity of diabetic ketoacidosis: a retrospective pilot study. J Fam Med Prim Care 7:787–790. https://doi.org/10.4103/jfmpc.jfmpc_116_18
Efstathiou SP, Tsiakou AG, Tsioulos DI et al (2002) A mortality prediction model in diabetic ketoacidosis. Clin Endocrinol (Oxf) 57:595–601. https://doi.org/10.1046/j.1365-2265.2002.01636.x
Novida H, Setiyawan F, Soelistijo SA (2021) A prediction model of mortality in patients hospitalized with diabetic ketoacidosis in a tertiary referral hospital in Surabaya, Indonesia. Indian J Forensic Med Toxicol 15:2519–2526. https://doi.org/10.37506/ijfmt.v15i2.14751
Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN (2009) Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32:1335–1343. https://doi.org/10.2337/dc09-9032
Haas NL, Whitmore SP, Cranford JA et al (2020) An emergency department-based intensive care unit is associated with decreased hospital and intensive care unit utilization for diabetic ketoacidosis. J Emerg Med 58:620–626. https://doi.org/10.1016/j.jemermed.2019.10.005
Braatvedt G, Kwan A, Dransfield W et al (2019) Differing protocols of managing adult diabetic ketoacidosis outside of the intensive care unit make no difference to the rate of resolution of hyperglycaemia and acidosis. N Z Med J 132:13–23
Chang DW, Shapiro MF (2016) Association between intensive care unit utilization during hospitalization and costs, use of invasive procedures, and mortality. JAMA Intern Med 176:1492–1499. https://doi.org/10.1001/jamainternmed.2016.4298
Sato Y, Morita K, Okada A et al (2021) Factors affecting in-hospital mortality of diabetic ketoacidosis patients: a retrospective cohort study. Diabetes Res Clin Pract 171:108588. https://doi.org/10.1016/j.diabres.2020.108588
Yamada K, Nonaka K (1996) Diabetic ketoacidosis in young obese Japanese men. Diabetes Care 19:671
Tanaka K, Moriya T, Kanamori A, Yajima Y (1999) Analysis and a long-term follow up of ketosis-onset Japanese NIDDM patients. Diabetes Res Clin Pract 44:137–146. https://doi.org/10.1016/S0168-8227(99)00023-6
Wachtel TJ, Tetu-Mouradjian LM, Goldman DL et al (1991) Hyperosmolarity and acidosis in diabetes mellitus—a 3 year experience in Rhode Island. J Gen Intern Med 6:495–502. https://doi.org/10.1007/BF02598216
Randall L, Begovic J, Hudson M et al (2011) Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabetes Care 34:1891–1896. https://doi.org/10.2337/dc11-0701
Yoshida M, McKeown NM, Rogers G et al (2007) Surrogate markers of insulin resistance are associated with consumption of sugar-sweetened drinks and fruit juice in middle and older-aged adults. J Nutr 137:2121–2127. https://doi.org/10.1093/jn/137.9.2121
den Biggelaar LJCJ, Sep SJS, Mari A et al (2020) Association of artificially sweetened and sugar-sweetened soft drinks with β-cell function, insulin sensitivity, and type 2 diabetes: the Maastricht Study. Eur J Nutr 59:1717–1727. https://doi.org/10.1007/s00394-019-02026-0
Hwang JL, Weiss RE (2014) Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diabetes Metab Res Rev 30:96–102. https://doi.org/10.1002/dmrr.2486
Sarafidis PA, Bakris GL (2006) Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control. QJM 99:431–436. https://doi.org/10.1093/qjmed/hcl059
Lean MEJ, Pajonk F-G (2003) Patients on atypical antipsychotic drugs. Diabetes Care 26:1597–1605. https://doi.org/10.2337/diacare.26.5.1597
Shafi T, Appel LJ, Miller ER et al (2008) Changes in serum potassium mediate thiazide-induced diabetes. Hypertension 52:1022–1029. https://doi.org/10.1161/HYPERTENSIONAHA.108.119438
Chou HW, Wang JL, Chang CH et al (2013) Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan. Clin Infect Dis 57:971–980. https://doi.org/10.1093/cid/cit439
Bonaventura A, Montecucco F (2018) Steroid-induced hyperglycemia: an underdiagnosed problem or clinical inertia? A narrative review. Diabetes Res Clin Pract 139:203–220. https://doi.org/10.1016/j.diabres.2018.03.006
Manu P, Correll CU, Van Winkel R et al (2012) Prediabetes in patients treated with antipsychotic drugs. J Clin Psychiatry 73:460–466. https://doi.org/10.4088/JCP.10m06822
Vuk A, Kuzman MR, Baretic M, Osvatic MM (2017) Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature. Psychiatr Danub 29:121–135. https://doi.org/10.24869/psyd.2017.121
Chinthapalli K, Newey A, Krause M (2015) Corticosteroid induced hyperosmolar hyperglycaemic state and hemiballismus. Oxford Med Case Rep 2015:320–322. https://doi.org/10.1093/omcr/omv051
Peters AL, Buschur EO, Buse JB et al (2015) Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care 38:1687–1693. https://doi.org/10.2337/dc15-0843
Nasa P, Chaudhary S, Shrivastava PK, Singh A (2021) Euglycemic diabetic ketoacidosis: a missed diagnosis. World J Diabetes 12:514–523. https://doi.org/10.4239/wjd.v12.i5.514
Acknowledgements
Not applicable
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
KT collected and analyzed the data and wrote the manuscript. NU designed the study and collected and analyzed the data. MS designed and directed the project. SU analyzed the data and supervised the manuscript. NY, TT, NN, HK, SO, KY, HY, SK, HT, NF, TK, TI, TK, KE, TM, TO, MH, AH, TM, YM, AY, TW, TU, TK, and TS collected and analyzed the data. AKL supervised the manuscript and provided a reliable edit to correct English language errors. All authors checked and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval and consent to participate
The study design was approved by the ethics committee of Jichi Medical University (ID: RINS17-023. Registered 4th September 2017) and each institution with a waiver of informed consent prior to collecting the data. The study was performed in accordance with the Declaration of Helsinki.
Informed consent
Due to the nature of the retrospective study, informed consent is waived, which was approved by the ethics commitiy in each institution. Instead, we kept all data completely anonymous and provided opportunities for opting out of the study.
Additional information
Managed By Massimo Federici.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Takahashi, K., Uenishi, N., Sanui, M. et al. Clinical profile of patients with diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome in Japan: a multicenter retrospective cohort study. Acta Diabetol 61, 117–126 (2024). https://doi.org/10.1007/s00592-023-02181-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-023-02181-1